Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.50 0.00 (0.00%)
As of 04/17/2025

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Key Stats

Today's Range
$0.50
$0.50
50-Day Range
$0.40
$0.60
52-Week Range
$0.31
$0.80
Volume
N/A
Average Volume
10,122 shs
Market Capitalization
$11.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

PBSV Returns to Growth
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…
PBSV Makes Progress on Improvements
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $0.5499 on January 1st, 2025. Since then, PBSV stock has decreased by 9.1% and is now trading at $0.4998.
View the best growth stocks for 2025 here
.

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) issued its quarterly earnings data on Monday, March, 17th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.35. The firm had revenue of $2.47 million for the quarter, compared to analysts' expectations of $2.70 million. Pharma-Bio Serv had a negative trailing twelve-month return on equity of 5.61% and a negative net margin of 8.18%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), General Electric (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

Record date for 3/20 Dividend
2/28/2025
Ex-Dividend for 3/20 Dividend
2/28/2025
Last Earnings
3/17/2025
Dividend Payable
3/20/2025
Today
4/19/2025
Next Earnings (Estimated)
6/13/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Management consulting services
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
Employees
185
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
4.54
P/E Growth
N/A
Net Income
$-780,000.00
Pretax Margin
-7.94%

Debt

Sales & Book Value

Annual Sales
$9.51 million
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
0.83

Miscellaneous

Free Float
20,162,000
Market Cap
$11.46 million
Optionable
Not Optionable
Beta
0.60

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners